IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2018 Holdings

Filed 2018-05-14 | 16 holdings | $10.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$10.4M163,92496.3%
United Therapeutics Corp(UTHR)COM91307C102$73.5K653,7870.7%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$59.9K739,7380.6%
Amgen Inc(AMGN)COM031162100$44.6K261,4200.4%
Mckesson Corp(MCK)COM58155Q103$41.0K291,3920.4%
Gilead Sciences Inc(GILD)COM375558103$39.4K522,0030.4%
Merck & Co. Inc.(MRK)COM58933Y105$30.1K552,2540.3%
RTI Surgical IncCOM74975N105$20.1K4,361,7870.2%
Invacare CorpCOM461203101$19.4K1,114,6580.2%
Halyard Health IncCOM40650V100$18.5K401,4000.2%
Shire PLCCOM82481R106$17.9K120,0000.2%
Siemens Healthineers AG(SHL)COMD6T479107$16.6K400,0000.2%
Orthofix International NVCOMN6748L102$15.7K267,0520.1%
Juniper Pharmaceuticals IncCOM48203L107$3.4K332,8380.0%
Vaxart Inc(VXRT)COM92243A200$1.4K256,9730.0%
Digirad CorpCOM253827109$552356,3470.0%